Menu
GeneBe

rs375088539

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_001363118.2(SLC52A2):c.808C>T(p.Gln270Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000627 in 1,610,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000067 ( 0 hom. )

Consequence

SLC52A2
NM_001363118.2 stop_gained

Scores

1
1
5

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: -1.12
Variant links:
Genes affected
SLC52A2 (HGNC:30224): (solute carrier family 52 member 2) This gene encodes a membrane protein which belongs to the riboflavin transporter family. In humans, riboflavin must be obtained by intestinal absorption because it cannot be synthesized by the body. The water-soluble vitamin riboflavin is processed to the coenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) which then act as intermediaries in many cellular metabolic reactions. Paralogous members of the riboflavin transporter gene family are located on chromosomes 17 and 20. Unlike other members of this family, this gene has higher expression in brain tissue than small intestine. Alternative splicing of this gene results in multiple transcript variants encoding the same protein. Mutations in this gene have been associated with Brown-Vialetto-Van Laere syndrome 2 - an autosomal recessive progressive neurologic disorder characterized by deafness, bulbar dysfunction, and axial and limb hypotonia. [provided by RefSeq, Jul 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-144360300-C-T is Pathogenic according to our data. Variant chr8-144360300-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 188051.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SLC52A2NM_001363118.2 linkuse as main transcriptc.808C>T p.Gln270Ter stop_gained 3/5 ENST00000643944.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SLC52A2ENST00000643944.2 linkuse as main transcriptc.808C>T p.Gln270Ter stop_gained 3/5 NM_001363118.2 P1

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152236
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000121
AC:
3
AN:
247964
Hom.:
0
AF XY:
0.0000149
AC XY:
2
AN XY:
134608
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000266
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000672
AC:
98
AN:
1458560
Hom.:
0
Cov.:
31
AF XY:
0.0000703
AC XY:
51
AN XY:
725594
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000827
Gnomad4 OTH exome
AF:
0.0000828
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152236
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74376
show subpopulations
Gnomad4 AFR
AF:
0.0000482
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000378
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000247
AC:
3
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Brown-Vialetto-van Laere syndrome 2 Pathogenic:2
Pathogenic, no assertion criteria providedresearchDuke University Health System Sequencing Clinic, Duke University Health SystemMar 25, 2015- -
Pathogenic, criteria provided, single submitterclinical testingInvitaeAug 30, 2023For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 188051). This premature translational stop signal has been observed in individual(s) with Brown-Vialetto-Van Laere syndrome (BVVLS) (PMID: 27148561). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs375088539, gnomAD 0.004%). This sequence change creates a premature translational stop signal (p.Gln270*) in the SLC52A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC52A2 are known to be pathogenic (PMID: 24253200). -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingGeneDxJun 21, 2023Not observed at a significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 27148561, 34493867, 31836589, 30487145) -
Brown-Vialetto-van Laere syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteSep 02, 2022A heterozygous nonsense variant was identified, NM_001253816.1(SLC52A2):c.808C>T in exon 3 of 5 of the SLC52A2 gene. This nonsense variant is predicted to create a change of a glutamine to a stop at amino acid position 270 of the protein; NP_001240745.1(SLC52A2):p.(Gln270*), resulting in the loss of normal protein function through nonsense-mediated decay (NMD). The variant is present in the gnomAD population database at a global population frequency of 0.0014% (4 heterozygotes, 0 homozygotes) with an African sub-population frequency of 0.0040%. The variant has been previously reported in patients with Brown-Vialetto-Van Laere syndrome (ClinVar, LOVD, Petrovski, S. et al. (2015)). Other variants predicted to cause NMD have also been reported as pathogenic in individuals with this Brown-Vialetto-Van Laere syndrome (ClinVar, Foley, A. R. et al. (2014)). Based on information available at the time of curation, this variant has been classified as PATHOGENIC. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.55
D
BayesDel_noAF
Uncertain
-0.060
Cadd
Pathogenic
27
Dann
Benign
0.96
Eigen
Benign
-0.39
Eigen_PC
Benign
-0.76
FATHMM_MKL
Benign
0.082
N
MutationTaster
Benign
1.0
A;A;A;A;A;A;N
Vest4
0.14
GERP RS
-1.4

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs375088539; hg19: chr8-145583960; COSMIC: COSV100095569; COSMIC: COSV100095569; API